Financials data is unavailable for this security.
View more
Year on year Genmab A/S had net income fall -20.18% from 5.45bn to 4.35bn despite a 13.57% increase in revenues from 14.51bn to 16.47bn. An increase in the selling, general and administrative costs as a percentage of sales from 18.19% to 19.74% was a component in the falling net income despite rising revenues.
Gross margin | 96.08% |
---|---|
Net profit margin | 23.47% |
Operating margin | 31.44% |
Return on assets | 12.39% |
---|---|
Return on equity | 14.72% |
Return on investment | 13.76% |
More ▼
Cash flow in DKKView more
In 2023, Genmab A/S increased its cash reserves by 50.28%, or 4.97bn. The company earned 7.38bn from its operations for a Cash Flow Margin of 44.80%. In addition the company used 1.28bn on investing activities and also paid 606.00m in financing cash flows.
Cash flow per share | 0.6561 |
---|---|
Price/Cash flow per share | 35.72 |
Book value per share | 7.23 |
---|---|
Tangible book value per share | 4.08 |
More ▼
Balance sheet in DKKView more
Current ratio | 5.17 |
---|---|
Quick ratio | 5.15 |
Total debt/total equity | 0.0309 |
---|---|
Total debt/total capital | 0.03 |
More ▼
Growth rates in DKK
SmartText is unavailable
EPS growth(5 years) | 22.71 |
---|---|
EPS (TTM) vs TTM 1 year ago | 12.29 |